Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

VolitionRx Limited (VNRX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

VolitionRx Limited (VNRX), most recent 12 months reported: revenue $2.46M, net loss $25.64M, free cash flow -$19.58M. From SEC filings. Others in In Vitro & In Vivo Diagnostic Substances: ImmuCell Corporation · Anbio Biotechnology · Aspira Women’s Health Inc. · BIOMERICA, INC. · Insight Molecular Diagnostics Inc. · Celldex Therapeutics, Inc. · Cardio Diagnostics Holdings, Inc. · Achieve Life Sciences, Inc.

Stock screener

Watchlist